PURPOSE: Fatty liver alters liver transporter expression. Caloric restriction (CR), the recommended therapy to reverse fatty liver, increases Sirtuin1 deacetylase activity in liver. This study evaluated whether CR and CR mimetics reversed obesity-induced transporter expression in liver and hepatocytes. METHODS: mRNA and protein expression was determined in adult lean (lean) and leptin-deficient obese (OB) mice fed ad libitum or placed on 40% (kCal) reduced diet. Hepatocytes were isolated from lean and OB mice, treated with AMP Kinase activators, and gene expression was determined. RESULTS: CR decreased Oatp1a1, Oatp1b2, and Abcb11 mRNA expression in lean, but not OB mice. CR increased Abcc2 mRNA OB livers, whereas protein expression increased in both genotypes. CR increased Abcc3 protein expression increased in OB livers. CR did not alter Abcc1, 4 and 5 mRNA expression in lean mice but decreased expression in livers of OB mice. CR increased Abcc4 protein in lean, but not OB mice. CONCLUSIONS: CR restriction reversed the expression of some, but not all transporters in livers of OB mice. Overall, these data indicate a potential for CR to restore some hepatic transporter changes in OB mice, but suggest a functional leptin axis is needed for reversal of expression for some transporters.
PURPOSE: Fatty liver alters liver transporter expression. Caloric restriction (CR), the recommended therapy to reverse fatty liver, increases Sirtuin1 deacetylase activity in liver. This study evaluated whether CR and CR mimetics reversed obesity-induced transporter expression in liver and hepatocytes. METHODS: mRNA and protein expression was determined in adult lean (lean) and leptin-deficient obese (OB) mice fed ad libitum or placed on 40% (kCal) reduced diet. Hepatocytes were isolated from lean and OBmice, treated with AMP Kinase activators, and gene expression was determined. RESULTS: CR decreased Oatp1a1, Oatp1b2, and Abcb11 mRNA expression in lean, but not OBmice. CR increased Abcc2 mRNA OB livers, whereas protein expression increased in both genotypes. CR increased Abcc3 protein expression increased in OB livers. CR did not alter Abcc1, 4 and 5 mRNA expression in lean mice but decreased expression in livers of OBmice. CR increased Abcc4 protein in lean, but not OBmice. CONCLUSIONS: CR restriction reversed the expression of some, but not all transporters in livers of OBmice. Overall, these data indicate a potential for CR to restore some hepatic transporter changes in OBmice, but suggest a functional leptin axis is needed for reversal of expression for some transporters.
Authors: Sarah J Schrieber; Roy L Hawke; Zhiming Wen; Philip C Smith; K Rajender Reddy; Abdus S Wahed; Steven H Belle; Nezam H Afdhal; Victor J Navarro; Catherine M Meyers; Edward Doo; Michael W Fried Journal: Drug Metab Dispos Date: 2011-08-24 Impact factor: 3.922
Authors: Jonathan M Maher; Matthew Z Dieter; Lauren M Aleksunes; Angela L Slitt; Grace Guo; Yuji Tanaka; George L Scheffer; Jefferson Y Chan; Jose E Manautou; Ying Chen; Timothy P Dalton; Masayuki Yamamoto; Curtis D Klaassen Journal: Hepatology Date: 2007-11 Impact factor: 17.425
Authors: Franck Rencurel; Marc Foretz; Michel R Kaufmann; Deborah Stroka; Renate Looser; Isabelle Leclerc; Gabriela da Silva Xavier; Guy A Rutter; Benoit Viollet; Urs A Meyer Journal: Mol Pharmacol Date: 2006-09-20 Impact factor: 4.436
Authors: Dorela D Shuboni-Mulligan; Maciej Parys; Barbara Blanco-Fernandez; Christiane L Mallett; Regina Schnegelberger; Marilia Takada; Shatadru Chakravarty; Bruno Hagenbuch; Erik M Shapiro Journal: Diabetes Date: 2018-11-28 Impact factor: 9.461
Authors: Jozaa Z ALTamimi; Ghedeir M Alshammari; Nora A AlFaris; Reham I Alagal; Dalal H Aljabryn; Norah A Albekairi; Mahmoud Ahmad Alkhateeb; Mohammed Abdo Yahya Journal: Pharm Biol Date: 2022-12 Impact factor: 3.503